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IntroDuctIon
Data from GWASs of different cohorts can be combined into a 
meta-analysis even when the samples of the cohorts have been 
typed on different genotyping platforms. By imputing missing 
genotypes, a homogeneous data set for meta-analysis can be 
created. Genotype imputation allows the estimation of genotypes 
in a target data set, based on one or more available reference sets 
of SNPs, and it is based on searching common haplotypes between 
an individual’s genome and a reference panel with a high density 
of genotyped SNPs, such as those provided by the HapMap1, 1000 
Genomes2 and the GoNL3–5 projects. Missing genotypes are then 
inferred from common haplotypes that are found in the reference 
set. Implementation of these methods usually results in estimates 
of the posterior probability distributions Pg = (PAA, PAB, PBB) of 
the genotypes based on the available data6.
Weaknesses in both genotype calling and imputation of 
missing genotypes can lead to biases in GWASs and subsequently 
in meta-analysis. Therefore, Anderson et al.7 have previously 
published a protocol dealing with quality control of genotype 
data, and our work can be seen as an extension of that protocol. 
A guideline for imputations with the Beagle8 and IMPUTE2 
(ref. 9) tools, as well as postimputation quality control, has 
also been published by Verma et al.10, and a protocol for doing 
meta-analysis of GWAS results for large numbers of cohorts is 
described in Winkler et al.11.
In this protocol, we show how to perform genotype imputations 
with a population-specific reference panel, including how to deal 
with factors that may adversely affect the imputation result (e.g., 
how to properly split up large data sets for imputation). This proto-
col differs from the previous guidelines in the study by Verma et al.10, 
providing instructions for imputations with IMPUTE2 (ref. 9) and 
minimac12. We describe the different pipelines for imputations 
using the genome-wide SNP data provided by Anderson et al.7 
as a target data set. We will start with the quality control of this 
target set using the pipeline from Anderson et al.7. We will show 
how to lift the target set over to the correct National Center 
for Biotechnology Information (NCBI) build and then provide 
pipelines for imputation using minimac12 and IMPUTE2 (ref. 9; 
Fig. 1). All pipelines are developed for GNU/Linux-based computer 
resources, and all commands should be typed at the Bash shell 
prompt, where Bash variables are indicated by ‘${variablename}’. 
This protocol does not include commands to submit compute 
intensive tasks to a job scheduling system such as OpenPBS (see 
‘Computer Resources’ section), as different computer clusters may 
use different scheduling systems.
This protocol has been used to impute the genotypes of 
individuals of various Dutch biobanks using the GoNL reference 
panel. This has resulted in the discovery of five novel associations 
at four loci for cholesterol levels including a rare missense variant 
in the ABCA6 gene, which is predicted to be deleterious13.
GoNL reference set
The construction of a novel imputation reference data set is a 
complex procedure that requires dense genotyping and accurate 
estimation of haplotypes from genotype data (known as phas-
ing) of samples from a specific population. The most thoroughly 
documented and widely available imputation reference sets come 
from the HapMap1 and 1000 Genomes projects2. Both projects 
contain samples from various populations, and consequently a 
given genotype of a low-frequency variant may not be represented 
adequately in the reference data set. Moreover, when the percent-
age of samples belonging to a different geographical population 
is beyond a certain proportion, the imputation quality does not 
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In order to meaningfully analyze common and rare genetic variants, results from genome-wide association studies (GWass) of 
multiple cohorts need to be combined in a meta-analysis in order to obtain enough power. this requires all cohorts to have the 
same single-nucleotide polymorphisms (snps) in their GWass. to this end, genotypes that have not been measured in a given 
cohort can be imputed on the basis of a set of reference haplotypes. this protocol provides guidelines for performing imputations 
with two widely used tools: minimac and IMpute2. these guidelines were developed and used by the Genome of the netherlands 
(Gonl) consortium, which has created a population-specific reference panel for genetic imputations and used this reference to 
impute various Dutch biobanks. We also describe several factors that might influence the final imputation quality. this protocol, 
which has been used by the largest Dutch biobanks, should take approximately several days, depending on the sample size of the 
biobank and the computer resources available.
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improve. Jostins et al.14 found that when 
imputing samples from the 1958 British 
Birth Cohort, the accuracy starts to fall 
off when the proportion of non-CEU 
(Northern Europeans from Utah; refs. 1,2) 
samples exceed 20%, as the effect of 
increased diversity is outweighed by the 
effect of mismatching. This relationship 
is specific to low-frequency variants. 
Moreover, Pistis et al.15 found that the 
effectiveness of population-specific refer-
ence panels can be appreciable for other 
populations, but that effectiveness will 
vary depending on the size of the panels 
and the demographic history of the isolate.
As interest in the field of genetic epidemiology is shifting 
toward low-frequency variants, the GoNL consortium has 
created a population-specific reference set for imputation with 
the goal of identifying associations between various phenotypes 
and low-frequency genetic variants. To this end, 231 parent- 
offspring trios and 19 parent-offspring quartets of Dutch descent 
had their complete genome sequenced with at least 12× cover-
age3–5. The strength of this reference set comes from several 
factors. The first is the trio design, which improves the haplotype 
quality. The second is the coverage, which is higher than that of 
the 1000 Genomes Project, and the third factor is the sequencing 
of samples from a homogeneous population. The quality of the 
haplotypes boosts imputation accuracy in independent samples, 
especially for lower-frequency alleles4.
The GoNL reference set is available by applying through 
http://www.nlgenome.nl/, menu option ‘Request data’, which 
leads to the application form. After filling in the form, the request 
will be evaluated by the GoNL steering committee. After a positive 
evaluation, a data access agreement needs to be signed and, 
subsequently, the reference panel can be downloaded in Variant 
Call Format (VCF). For this protocol, the fourth release of the 
GoNL reference panel was used, which contains 499 individuals 
of Dutch ancestry and 19,562,004 autosomal SNPs.
Tools for imputation
The three most commonly used tools for genotype imputation 
are minimac12, IMPUTE2 (ref. 9) and Beagle8. Multiple aspects 
of the three tools, e.g., their imputation accuracy, error rates and 
computational performance, have been compared previ-
ously6,10,16,17. The choice for a given tool depends on the target set 
that is to be imputed and on the type of computational resources 
available, as discussed in this paper. Within the GoNL3–5 consor-
tium, only minimac and IMPUTE2 were used for imputations, 
and therefore Beagle will not be discussed in this manuscript. It 
is, however, possible to impute samples with the GoNL reference 
panel using Beagle. Minimac can be downloaded freely from the 
web, and its source code is available under an open-source license. 
IMPUTE2 is available for download for academic use only; 
no source code is provided.
IMPUTE2 performs both the phasing and the imputation, 
whereas minimac only imputes data sets that have been phased 
by MaCH18 or SHAPEIT2 (ref. 19). However, although IMPUTE2 
can perform phasing, its authors recommend using SHAPEIT2 
(ref. 19), followed by using IMPUTE2 for the imputations. Of the 
three tools, only IMPUTE2 can combine two reference panels. 
This allows imputation with both the 1000 Genomes reference 
panel and the GoNL reference panel, which has been shown to 
improve imputation quality3. MaCH and minimac make their 
own recombination maps on the basis of input data; IMPUTE2 
requires a recombination map.
The requested file format of the reference set is also different 
among the tools. The GoNL project3–5, the 1000 Genomes project2 
and the HapMap project1 provide their data in VCF format20. The 
VCFtools20 software package can convert these VCF files into phased 
haplotypes in IMPUTE2 reference-panel format. The authors of 
IMPUTE2 also provided a Perl script to perform this conversion. 
Minimac can handle the original VCF files without conversion.
Figure 1 | Workflow of the imputation protocol 
for imputations of unobserved genotypes with 
the GoNL reference panel. The first stage of the 
protocol is to perform quality control of the 
target data set consisting of measured genotypes; 
this followed by performing the liftover to the 
correct human genome build. The human genome 
build of the GoNL reference panel is UCSC hg19. 
These steps are independent of the tools that are 
used for the actual phasing and imputation. The 
next step is to download the reference set, which 
is necessary to create the correct input file for 
phasing and imputations. The reference set file 
format is different for each tool. Next, MaCH or 
SHAPEIT is used for phasing, followed by minimac 
and IMPUTE2 for the imputations. 
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Both tools produce several output files. The first one is the 
so-called ‘info file,’ which contains the SNP name, the base-pair 
positions, the frequencies of the alleles and the R2. Here R2 is 
the estimated squared correlation (between zero and one) 
between the allele dosage with highest posterior probability 
in the genotype probabilities file and the true allele dosage for 
the marker; larger values of allelic R2 indicate a more accurate 
genotype imputation. In a second file, IMPUTE2 gives the 
probabilities of the three genotypes AA, AB and BB, whereas 
minimac gives the probability of a homozygote for allele 1 and 
the probability of the heterozygote. Only minimac has the option 
to output best-guess alleles. Dosage files are produced only by 
minimac; however, it takes only one additional step to convert the 
genotype probabilities from IMPUTE2 into dosages. If a sample 
has genotype probabilities (PAA, PAB, PBB) for a marker, then the 
estimated B-allele dosage (dB) is dB = PAB + 2 PBB. All formats 
can be converted using fcGENE21.
Quality control of the target data set 
To achieve a high-quality imputation standard, GWAS quality 
control filters need to be applied to the target data set and, 
if necessary, also to the reference set before imputation. The 
purpose of these filters is to exclude both markers and samples 
with low-quality data. Anderson et al.7 and Verma et al.10  
provide a detailed protocol that deals with both per-maker and 
per-individual filtering.
Other factors that influence the imputation quality are the 
type of arrays used for genotyping, and strand and build issues. 
Present-day high-density arrays are of high quality; however, the 
low-density arrays used in the beginning of the GWAS era were 
less so. It is therefore useful to check the type of array that was 
used for genotyping of the target set. The genotype calls from 
the arrays are aligned to a specific strand22. In order to obtain 
high-quality imputations, it is important to correct possible 
strand alignment issues. Although IMPUTE2 and MaCH have 
options to fix misaligned alleles between the study and the refer-
ence panel by inverting the alleles when possible, the alignment of 
the target set should be fixed before imputing the target set with, 
e.g., SHAPEIT2 (ref. 19). This only holds for ambiguous strands 
(e.g., AT and TA); detecting and correcting the strand of the non-
ambiguous SNPs (e.g., AT and GC) is more of a challenge. Deelen 
et al.23 have published a method for solving the strand issues of 
nonambiguous SNPs. For imputation purposes, the alleles should 
be aligned to the forward strand, as the imputation tools assume 
that the target set is on the same strand as the reference panel, 
which is the forward strand.
It is important for imputation that both the target set and the ref-
erence set are on the same NCBI build, as SNP names may change 
or SNPs may be relocated or merged between builds. Release 4 of 
the GoNL reference set uses (NCBI) build 37 (human genome 19, 
hg19). If the reference and the target set are aligned using a 
different genome assembly, it is recommend to re-align the target 
panel to the assembly of the reference rather than the other way 
around. This is because the phased haplotype structure of the 
reference panel will be distorted if the position of the markers 
is altered. Moreover, re-aligning of the target set takes less time 
compared with re-aligning of the reference panel. The liftOver 
tool from the University of California, Santa Cruz (UCSC)24 
converts genome positions between different genome builds 
(see ‘Performing quality control’ section and http://genome.sph.
umich.edu/wiki/LiftOver).
A major pitfall of genotype imputation is a difference between 
groups of individuals, which, after imputation, can be (falsely) 
associated with a phenotype. Array differences or quality dif-
ferences (e.g., call rates) between cases and controls should be 
avoided. Therefore, the most ideal situation would be to genotype 
all individuals on the same array. If this is not possible, it is highly 
advised to apply strict quality control. The type of array also influ-
ences the imputations; chunking the observed genotypes of low-
density arrays as discussed in ‘Handling large target data sets’ 
below may lead to empty chunks. High-density genotype arrays 
are therefore advised. Other important imputation pitfalls are 
monomorphic and extremely rare SNPs25; therefore, these should 
be removed from both the target set and the reference panel.
After performing all quality control steps, the target data set 
needs to be converted into the correct input format (Box 1) for 
the imputation tool of choice.
Quality metrics 
The quality of an imputation experiment can be assessed by vari-
ous metrics10. These metrics can be divided into two categories 
on the basis of whether true genotypes are available or not. The 
most common imputation metric is the R2 that represents the 
correlation between the imputed and the real genotypes.
When the true genotypes are unknown, various statistics can be 
used to estimate the R2. Marchini and Howie6 present a thorough 
review of the R2 metrics used by MaCH, Beagle, SNPTEST and 
IMPUTE2. Comparison of these measures showed that they are 
highly correlated. Another R2 metric26 is the ratio of the vari-
ance of the imputed allele dosage and the variance of the true 
allele dosage. Although the variance of the true allele dosage is 
unknown, it can be estimated as 2p(1–p) under Hardy-Weinberg 
equilibrium, where p is the estimated allele frequency. To illustrate 
how well rare and common SNPs were imputed, a plot can be 
made with the percentage of SNPs at various cutoffs for the R2 
for various minor allele frequency bins8,27.
When the true genotypes are available, the quality of the impu-
tation can also be evaluated by calculating the false-positive and 
false-negative genotypes4. False-positive genotypes are those that 
have a high imputation R2, but that were in fact imputed incor-
rectly. False-negative genotypes are those that have a low R2, but 
that were actually imputed correctly. Another qualitative metric 
is the concordance between real and imputed genotypes. A graph 
of the percentage of discordance versus the percentage of missing 
genotypes for various thresholds of the genotype probability can 
be used to compare different imputation methods9.
Handling large target data sets 
To successfully identify rare variants associated with particular 
phenotypes, large sample sizes are needed. Moreover, the number 
of variants in the reference panels are increasing, both leading to 
increasing computation times. Splitting up the target sets and 
distributing the computational burden of phasing and imputa-
tion over several computers allows imputation of such large sets 
to finish within a reasonable time frame. Splitting up the target 
set reduces the time to finish the imputations (Supplementary 
Fig. 1); however, it requires a computer cluster. A target set can 
be split up in two ways: it can be split into subsets of samples 
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or split into chunks of chromosomes. The division into groups 
of samples can be done randomly, although the distribution of 
cases and controls should be similar in the subgroups. However, 
as imputations are mostly done once per cohort followed by the 
subsequent analysis of many phenotypes using the same imputed 
genotype data, splitting a target set into equal proportions of 
cases and controls provides a challenge, and we therefore do not 
recommend this. This only holds for the imputations and not 
for phasing, as the samples do not affect each other in phasing. 
Splitting up into samples may, however, be helpful to optimize 
the capacity utilization of a compute cluster.
The second, more useful, strategy for dividing up the target set 
is to split the chromosomes into chunks of a few Mb. Depending 
on the imputation tool, the strategy to split up into chunks is 
different. When using minimac, the ChunkChromosome tool 
(http://genome.sph.umich.edu/wiki/ChunkChromosome) 
can be used to split each chromosome before imputation (see 
Step 10A(viii)). When imputing with IMPUTE2, it is not necessary 
to first split up the chromosome, as one of the command-line 
arguments of IMPUTE2 is the position interval to impute.
To evaluate the quality of the imputations after the chromo-
some is split into chunks, we imputed chromosome 21 of all 5,974 
samples of the Rotterdam Study cohort I with the European part 
of the 1000 Genomes reference set (release August 2010) using 
minimac after phasing with MaCH using two approaches. In both 
approaches, the data set was split up before phasing with MaCH. 
The first approach was to split the SNPs on chromosome 21 into 
chunks of 500 kb, 1, 2, 3, 4, 5, 7.5 and 10 Mb, respectively, each with 
an overlap of 5% on each side of the chunk. The second approach 
was to split the same chromosome into chunks of 5 Mb with an 
overlap of 2.5% (250 kb), 5% (500 kb), 7.5% (750 kb), 10% (1 Mb) 
and 12.5% (1.25 Mb) on each side, respectively. Figure 2 shows that 
the target set can be split into subsets of at least 5 Mb with an over-
lap of at least 250 kb without decreasing the imputation quality.
Box 1 | Input files for imputations 
the input files for the various imputation tools
For MaCH and minimac, the target set that will be imputed needs to be stored per chromosome in Merlin28 format. The Merlin pedigree 
file contains the relationships, the phenotypes and the genotypes per individual per row. The first columns of the pedigree file contain 
the family identifier, the individual identifier, the father and mother identifiers, and the sex of the individual (with females decoded  
as 2 and the males decoded as 1). The subsequent columns can encode phenotypes for discrete and quantitative traits followed by  
the genotypes. The alleles should be coded as ‘A’, ‘C’, ‘G’ or ‘T’ and missing alleles should be encoded with ‘N’, ‘X’ or ‘0’. As MaCH and 
minimac assume samples to be unrelated, both the father and mother identifiers should be zero. The description of the columns is 
stored in the data file, with one row per column, indicating the data type (encoded as M, marker; A, affection status; T, quantitative 
trait; and C, covariate) and providing a one-word label for each column.
 For IMPUTE2, the genotype information should be stored in a one-line-per-SNP format. The first five entries of each line should be 
the SNP ID, rs ID of the SNP, base-pair position of the SNP, the allele coded A and the allele coded B. The subsequent columns contain 
the prior probabilities for the three genotypes AA, AB and BB for each individual in the target set. This format allows for genotype 
uncertainty, and therefore the probabilities for a given individual need not sum to 1. The order of samples in the genotype file should 
match the order of the samples in the sample file. The sample file has three parts: (i) a header line detailing the names of the columns 
in the file, (ii) a line detailing the types of variables stored in each column and (iii) a line for each individual detailing the information 
for that individual (more details on the IMPUTE2 file formats can be found at http://www.stats.ox.ac.uk/~marchini/software/gwas/
file_format.html).
plInK format to store genotyped data
The most commonly used file format for storing genotype data of the samples in the target set is the PLINK format (http://pngu.mgh.
harvard.edu/~purcell/plink/data.shtml#ped). The pedigree file (extension .ped) in PLINK format is a headerless white space (space  
or tab)-delimited file that contains the pedigree information, the phenotype information and the genotype information for all  
samples in the data set. Every row corresponds to one individual and contains at least six columns, which contain the family identifier, 
the individual identifier, the paternal and maternal identifier, the sex of the samples (with males encoded as 1 and females encoded 
as 2) and the phenotype of the sample, just like the Merlin format. Genotypes (column 7 onward) can be any character (e.g., 1, 2, 3 
and 4 or A, C, G and T or anything else) except 0, which is, by default, the missing genotype character. All markers should be biallelic. 
All SNPs (whether haploid or not) must have two alleles specified, and either both or neither alleles should be missing. The SNPs are 
described in the map file (extension .map); each line of this file describes a single marker, and it must contain exactly four columns: 
the chromosome, the SNP identifier, the genetic distance in Morgans and the base-pair position in base-pair units. The ped and map 
file can be converted into a more memory- and time-efficient binary file with the extensions .bed, .bim and .fam.
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Figure 2 | The percentage of SNPs with R2 > 0.3 after imputing chromosome 
21 of 5,974 samples of Rotterdam Study cohort I when the target set is split 
into several chunks of chromosomes and the percentage overlap between 
chunks is 10%, and when the chromosome of the target set is split into 5 Mb 
chunks and the size of the overlap is varied. This figure illustrates that the 
target set can be split into subsets of at least 5 Mb with an overlap of at 
least 250 kb without decreasing the imputation quality. Asterisks indicate 
data points on the graphs. 
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MaterIals
EQUIPMENT
 crItIcal This protocol assumes that the computer uses GNU/Linux  
as its operating system (which is the case for most, if not all, computer  
clusters), and that the analyst uses Bash as his/her shell (which is the  
default on most GNU/Linux systems).
Data
Genome-wide SNP data (raw-GWA-data.tgz). See the supplementary  
material in Anderson et al.7 for an example data set
GoNL reference panel for imputations. The reference set is available by  
applying through http://www.nlgenome.nl/ 
Software
Several tools such as gawk, sort, uniq, wget, tar, sed and head, which  
are usually installed by default on a GNU/Linux system
PLINK v1.07 (ref. 22): the binaries compiled for various platforms  
and installation instructions can be downloaded from http://pngu.mgh.
harvard.edu/~purcell/plink/download.shtml
liftOver: this tool can be used to lift over from one human genome build 
to the other, and it can be downloaded from http://pngu.mgh.harvard.
edu/~purcell/plink/download.shtml#download
VCFtools v0.1.12b: this tool can be downloaded from  
http://sourceforge.net/projects/vcftools/files/latest/download/vcftools_
0.1.12b.tar.gz
ChunkChromosome (release 2014-05-27): this tool can be downloaded 
from http://www.sph.umich.edu/csg/cfuchsb/generic-ChunkChromosome-
2014-05-27.tar.gz
MaCH (release 1.0): this tool can be downloaded from http://www.sph.
umich.edu/csg/abecasis/MaCH/download/mach.1.0.18.Linux.tgz
•
•
•
•
•
•
•
•
Minimac (release 2013.7.17): this tool can be downloaded from  
http://www.sph.umich.edu/csg/cfuchsb/minimac-beta-2013.7.17.tgz
SHAPEIT v2.790: this tool can be downloaded from https://mathgen.stats.
ox.ac.uk/genetics_software/shapeit/shapeit.v2.r790.RHELS_5.4.static.tar.gz  
IMPUTE2 v2.3.1: this tool can be downloaded from https://mathgen.stats.
ox.ac.uk/impute/impute_v2.3.1_x86_64_static.tgz
EQUIPMENT SETUP
Computer resources Imputing SNPs in data sets of several thousands of  
samples using reference sets consisting of several millions of SNPs (e.g., 
HapMap1) up to several tens of millions of SNPs (GoNL project3–5 or the 1000 
Genomes project2) cannot be done on a commodity desktop computer, as that 
would take months of time and it requires more memory (RAM) than is  
usually available. As discussed earlier, the answer lies in splitting the imputation 
task into smaller pieces and running these subtasks on a computer cluster.
The work described in this paper was done on two such clusters. The Lisa 
cluster at SARA (https://userinfo.surfsara.nl/systems/lisa/) is a heterogeneous 
cluster that consists of more than 500 machines with a total of at least  
6,000 cores and 16–24 GB of RAM each, running Debian Linux (http://www.
debian.org). The Millipede cluster at Groningen University is a heterogeneous  
cluster with 252 nodes with a total of 3,216 cores and 24–128 GB of RAM each. 
It runs RedHat Enterprise Linux 5 (http://www.redhat.com/en/technologies/
linux-platforms/enterprise-linux). Both clusters use the OpenPBS  
(http://www.mcs.anl.gov/research/projects/openpbs/) system to schedule 
tasks across their nodes.
The memory requirements for MaCH are ~100 MB. The minimac protocol 
requires 3 GB, whereas SHAPEIT requires ~1.5 MB and IMPUTE2 requires ~3 GB.
•
•
•
proceDure
performing quality control ● tIMInG ~8 h
1| The first step is to perform standard quality control on the target set. To do this, complete the protocol for quality  
control, as described by Anderson et al.7. We assume that the genotypes have been called by a genotyping center and  
returned in PLINK format named ‘raw-GWA-data.ped, raw-GWA-data.map’. All genotypes are annotated to the forward  
strand. After performing quality control of this genome-wide SNP data, 1,919 samples and 313,878 markers remain.  
The resulting files are named ‘clean-GWA-data.bed, clean-GWA-data.bim’ and ‘clean-GWA-data.fam’.
converting the target set to the correct genome build ● tIMInG ~20 min
2|  If the target set is on another genome build than the reference set, it is important to lift the target set over to the 
same build as the reference set. The following steps show how to convert the target set from UCSC hg17 (NCBI build 35) 
to UCSC hg19 (Genome Reference Consortium GRCh37).
First download the chain file
wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg17/liftOver/hg17ToHg19.over.chain.gz
Next, type the following to unzip the chain file.
gunzip hg17ToHg19.over.chain.gz
3|  Start the liftover by converting the target set with PLINK to a map and ped file. This will create the ‘clean-GWA-data.map’  
and ‘clean-GWA-data.ped’ files.
plink --noweb --bfile clean-GWA-data --recode --out clean-GWA-data
4| The next step is to create a BED file based on the map file using the following command:
gawk '{print "chr"$1, $4, $4+1, $2}' OFS="\t" clean-GWA-data.map > clean-
GWA-data_HG17.BED
5| Perform the liftover:
./liftOver -bedPlus=4 clean-GWA-data_HG17.BED hg17ToHg19.over.chain clean-
GWA-data.HG19.BED clean-GWA-data_unmapped.txt 
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6| Use the resulting file ‘clean-GWA-data_unmapped.txt’ to create a list of unmapped SNPs:
gawk '/^[^#]/ {print $4}' clean-GWA-data_unmapped.txt > clean-GWA-
data_unmappedSNPs.txt
7| Create a mapping file using the new BED file:
gawk '{print $4, $2}' OFS="\t" clean-GWA-data.HG19.BED > clean-GWA-
data.HG19.mapping.txt
8| Use PLINK to remove the unmapped SNPs from the target data set:
plink --noweb --file clean-GWA-data --exclude clean-GWA-
data_unmappedSNPs.txt --update-map clean-GWA-data.HG19.mapping.txt --make-
bed --out clean-GWA-data.HG19.temp
plink --noweb --bfile clean-GWA-data.HG19.temp --recode --out clean-GWA-data.HG19
9| Create a new SNP list for the data set:
gawk '{print $2}' clean-GWA-data.HG19.map > clean-GWA-data.HG19.snplist
The resulting files that are produced after quality control and after lifting over the data set to the correct build  
are named ‘clean-GWA-data.HG19.map’ and ‘clean-GWA-data.HG19.ped’. In this case, the data set was lifted over from 
build 35 to build 37; however, other liftovers are also possible. The UCSC Genome Browser website provides multiple 
chain files.
Imputations with minimac or IMpute2
10| SNP imputations can be performed using either a combination of MaCH/minimac (option A) or IMPUTE2 (option B).
(a) MacH/minimac ● tIMInG ~60 h
 (i)  Downloading the reference set for minimac. This pipeline for imputations with MaCH and minimac imputes the target 
set after quality control and if the target set is on another genome build than the reference set, the target set is  
lifted over to the same build of the GoNL reference panel release 4. First, create a new directory for the reference set: 
‘mkdir reference-GoNL-v4’. The zipped VCF files of the GoNL reference panel should be placed in this directory. In this 
protocol, we assume that the names of the files are as follows: ‘gonl.chr{1-22}.release4.gtc.vcf.gz’.
 (ii)  Use VCFtools to create info files for all chromosomes by running the following command:
for chr in {1..22}; do
   vcftools –-gzvcf reference-GoNL-
   v4/gonl.chr${chr}.release4.gtc.vcf.gz --get-INFO NS --out
   reference-GoNL-v4/gonl.chr${chr}.release4.gtc;
done
 (iii)  Create a file with all the positions that are in the reference set:
rm –f snps-reference.txt
for i in reference-GoNL-v4/gonl.chr*.release4.gtc.INFO; do
   gawk '$1!="CHROM" {print $1"_"$2}' $i >> snps-reference.txt;
done
 (iv)  Creating the input files for phasing and imputation. To get a list of positions of SNPs that are in the target set and/or 
in the reference set, use the following commands:
gawk '{print $1"_"$4}' clean-GWA-data.HG19.map > snps-reference-and-rawdata
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and
sort snps-reference.txt | uniq >> snps-reference-and-rawdata
To get only those SNPs that are in both the target set and reference set, use the following command:
sort snps-reference-and-rawdata | uniq -d | gawk -F "_" '{$3=$2+1;
print $1, $2, $3, "R"NR}' > snps-reference-and-rawdata-duplicates
? trouBlesHootInG
 (v)  The names of the SNPs that are in both the target set and in the reference set need to be extracted from the target 
set. Use PLINK to do this as follows:
plink --noweb --file clean-GWA-data.HG19 --extract snps-reference-and-rawdata-
duplicates --range --make-bed --out clean-GWA-data.HG19.for-impute.plink
 (vi) MaCH and minimac need one file per chromosome. Extract SNPs for each chromosome:
for chr in {1..22}; do
   plink -–noweb --bfile clean-GWA-data.HG19.for-impute.plink-
   chr ${chr} --recode --out clean-GWA-data.HG19.for-
   impute.plink.chr${chr};
done
 (vii) Convert the resulting PLINK sets into merlin file format, as minimac requests this:
for chr in {1..22}; do
   gawk '{$6=0; print $0}' clean-GWA-data.HG19.for-
   impute.plink.chr${chr}.ped > clean-GWA-data.HG19.for-
    impute.merlin.chr${chr}.ped;
   echo "T faket1" > clean-GWA-data.HG19.for-
   impute.merlin.chr${chr}.dat;
   gawk '$2="M"$2 {print $2}' clean-GWA-data.HG19.for-
   impute.plink.chr${chr}.map >> clean-GWA-data.HG19.for
   impute.merlin.chr${chr}.dat;
   echo "chromosome markername position" > clean-GWA-data.HG19.for-
   impute.merlin.chr${chr}.map;
   gawk '{print $1, $2, $4}' clean-GWA-data.HG19.for-
   impute.plink.chr${chr}.map >> clean-GWA-data.HG19.for-
   impute.merlin.chr${chr}.map;
done
 (viii)  Split the merlin files so that they contain 2,500 markers with a 500-marker overlap using the  
ChunkChromosome tool:
for chr in {1..22}; do
    ./generic-ChunkChromosome/executables/ChunkChromosome -d
    clean-GWA-data.HG19.for-impute.merlin.chr${chr}.dat -n 2500 -o 500;
done
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 (ix) Using MaCH for phasing. Use MaCH to phase the haplotypes in each chunk:
for chunk in chunk*.dat; do
   machfile="${chunk%.*}";
   merlinfile="${machfile#*-}.ped";
   executables/mach1 -d ${chunk} -p ${merlinfile} --rounds 20 -
   states 200 --phase --interim 5 --sample 5 --compact --prefix
   ${machfile};
done
? trouBlesHootInG
 (x) Imputation with minimac. Execute the following commands to impute all chunks using minimac:
  for chunk in chunk*.dat; do
  filename1="${chunk%.*}";
  filename2="${filename1#*-}.ped";
  chr=`echo "${filename1##*.}" | sed 's/chr//'`;
  minimac --vcfReference --rs --refHaps reference-GoNL-
  v4/gonl.chr${chr}.release4.gtc.vcf.gz --haps ${filename1}.gz
  --snps ${filename1}.dat.snps --rounds 5 --states 200 --autoClip
  autoChunk-clean-GWA-data.HG19.for-impute.merlin.chr${chr}.dat
  --gzip --phased --probs --prefix ${filename1};
  done
? trouBlesHootInG
(B) IMpute2 ● tIMInG ~7 h
 (i)  Downloading the reference set for IMPUTE2. This pipeline for imputations with IMPUTE2 imputes the target set  
after quality control and if the target set is on another genome build than the reference set, the target set is lifted 
over to the same build of the GoNL reference panel release 4. First, create a new directory for the reference set:  
'mkdir reference-GoNL-v4'. All files of the GoNL reference panel should be placed in this directory. In this protocol, we 
assume that the names of the files are as follows: 'gonl.chr{1–22}.release4.gtc. {hap.gz, legend.gz, geneticmap.txt}'.
 (ii) Now create a file with all the SNP names that are in the reference set:
rm –r snps-reference.txt;
for chr in {1..22}; do 
   gunzip -c reference-GoNL-
   v4/gonl.chr${chr}.release4.gtc.legend.gz | gawk -v chr=${chr}
   '$5=="SNP" && $1!="id" {print chr"_"$2}' >> snps-
   reference.txt;
done
 (iii)  Creating the input files for phasing and imputation. Use the following commands to get a list of positions of SNPs that 
are in the target set and/or in the reference set:
gawk '{print $1"_"$4}' clean-GWA-data.HG19.map > snps-reference-and-rawdata
and
sort snps-reference.txt | uniq >> snps-reference-and-rawdata
To get only those SNPs that are in both the target set and reference set, use the following command:
sort snps-reference-and-rawdata | uniq -d | gawk -F "_" '{$3=$2+1; print $1, $2,
$3, "R"NR}' > snps-reference-and-rawdata-duplicates
? trouBlesHootInG
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 (iv)  The names of the SNPs that are in both the target set and in the reference set need to be extracted from the target 
set. Use PLINK to run the following command. This creates the following files per chromosome: ‘clean-GWA-data.HG19.
for-impute.plink.chr${chr}.ped’ and ‘clean-GWA-data.HG19.for-impute.plink.chr${chr}.map’.
plink --noweb --file clean-GWA-data.HG19 --extract snps-reference-and-rawdata-
duplicates --range --make-bed --out clean-GWA-data.HG19.for-impute.plink
 (v)  As we will phase per chromosome, split the PLINK file into 22 files:
for chr in {1..22}; do
  plink --bfile clean-GWA-data.HG19.for-impute.plink --chr $chr --recode --out
  clean-GWA-data.HG19.for-impute.plink.chr${chr};
done
? trouBlesHootInG
 (vi) Using SHAPEIT for phasing. For every chromosome, phase the haplotypes using SHAPEIT:
for chr in {1..22}; do
     namefile="clean-GWA-data.HG19.for-impute.plink.chr${chr}";
        ./shapeit.v2.r790.RHELS_5.4.static --input-ped
        ${namefile}.ped ${namefile}.map --input-map reference-
        GoNL-v4/gonl.chr${chr}.release4.gtc.geneticmap.txt --
        output-max ${namefile}.phased --thread 8 --output-log
        ${namefile}.phased;
done
 (vii) Imputation with IMPUTE2. For every chromosome, perform imputations in chunks of 5 Mb:
refdir="reference-GoNL-v4";
for chr in {1.22}; do
   namefile="clean-GWA-data.HG19.for-
   impute.plink.chr${chr}.phased";
   maxPos=$(gawk '$1!="position" {print $1}'
   ${refdir}/gonl.chr${chr}.release4.gtc.geneticmap.txt | sort -n
   | tail -n 1);
   nrChunk=$(expr ${maxPos} "/" 5000000);
   nrChunk2=$(expr ${nrChunk} "+" 1);
   start="0";
   for chunk in $(seq 1 $nrChunk2); do
      endchr=$(expr $start "+" 5000000);
      startchr=$(expr $start "+" 1);
      ./impute_v2.3.1_x86_64_static/impute2 
      -known_haps_g ${namefile}.haps
      -m ${refdir}/gonl.chr${chr}.release4.gtc.geneticmap.txt 
      -h ${refdir}/gonl.chr${chr}.release4.gtc.hap.gz
      -l ${refdir}/gonl.chr${chr}.release4.gtc.legend.gz
      -int ${startchr} ${endchr} -Ne 20000 -o
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      ${namefile}.chunk${chunk}.impute2;
   start=${endchr};
   done
done
? trouBlesHootInG
 (viii) Convert the files with the probabilities for the three genotypes into dosage files:
  for chr in {1.22}; do
   namefile="clean-GWA-data.HG19.for-
   impute.plink.chr${chr}.phased";
   maxPos=$(gawk '$1!="position" {print $1}' 
   ${refdir}/gonl.chr${chr}.release4.gtc.geneticmap.txt | sort -n
   | tail -n 1);
   nrChunk=$(expr ${maxPos} "/" 5000000);
   nrChunk2=$(expr ${nrChunk} "+" 1);
   for chunk in $(seq 1 $nrChunk2); do 
       gawk '{tp = $1 " " $2 " " $3 " " $4 " " $5; for (i=6;
   i<=NF; i+=3) tp = tp " " $(i+1) + 2.0*$(i+2); print tp }'
   ${namefile}.chunk${chunk}.impute2 >
   ${namefile}.chunk${chunk}.impute2.dosage;
   done
done
? trouBlesHootInG
It is likely that many of the tools used in this protocol will be updated as time passes; we therefore recommend checking 
whether there are new versions of the tools each time the protocol is run and what the changes between versions are.
Imputation with MaCH and minimac, Step 10A(iv), and imputation with IMPUTE2, Step 10B(iii). This step checks the  
concordance between SNPs within the target set and the reference panel based on the position on the chromosome, by  
assuming that the SNP names are equal in both. This requires both panels to be aligned to the correct human genome build. 
Another option is to leave the SNPs that are in the target set and not in the reference panel. In that case, Step 10A(iv,v)  
(for MaCH and minimac) or Step 10B(iii, iv (for IMPUTE2) can be replaced by 'plink --noweb --file clean-GWA-data.HG19 --
make-bed --out clean-GWA-data.HG19.for-impute.plink.' It is also important to have both the target set and the  
reference panel on the same human genome build, as IMPUTE2 links the two panels according to chromosome and  
position, not SNP name.
Imputation with MaCH and minimac, Step 10A(ix). The command-line parameters ‘--interim 5’ (to save intermediate  
results), ‘--sample 5’ (random (but plausible) sets of haplotypes for each individual should be drawn every five iterations) and 
‘--compact’ (reduces memory use at the cost of runtime) can be removed from the command line to save time and disk space.
Imputation with MaCH and minimac, Step 10A(x). The command-line parameter ‘--rs’ allows the use of rs GWAS SNP  
identifiers in the target set. This command-line parameter can be removed if the target set does not include rs identifiers.
Imputation with IMPUTE2, Step 10B(v). To increase the speed of the IMPUTE2 protocol, the target set could be  
reformatted into binary PLINK format (Box 1); therefore, the ‘--recode’ command should be replaced by '--make-bed'.  
The follow-up Step 10B(vi, vii) should be adjusted for binary files in that case.
Imputation with IMPUTE2, Step 10B(vii). When the analyst wants to use two phased reference panels, the IMPUTE2  
command should be replaced with
./impute_v2.3.1_x86_64_static/impute2 -known_haps_g
${namefile}.haps -m ${refdir}/gonl.chr${chr}.release4.gtc.geneticmap.txt -h 
${refdir}/gonl.chr${chr}.release4.gtc.hap.gz 
${refdir}/1000g.chr${chr}.release4.gtc.hap.gz -l 
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${refdir}/gonl.chr${chr}.release4.gtc.legend.gz 
${refdir}/1000g.chr${chr}.release4.gtc.legend.gz -int ${startchr} ${endchr} -Ne
20000 -o ${namefile}.chunk${chunk}.impute2;
When combining several of the commands into Bash shell script files, be sure to add ‘set –e’ and ‘set –u’ as the first  
two actual commands in the script. This makes sure that the script halts on errors and when undefined variables are  
being used, respectively. If additional debugging of Bash scripts is required, running a script such as ‘bash -x scriptfile.sh’ 
will run the script in debug mode, showing the value of variables and so on. Alternatively, if only a certain part of a  
Bash script is to be debugged, adding ‘set –x’ before and ‘set +x’ after the problematic part will enable debugging only  
for that part.
● tIMInG
Step 1, performing quality control: ~8 h
Steps 2–9, converting the target set to the correct build: ~20 min
Step 10, imputations with minimac or IMPUTE2:
Step 10A, MaCH/minimac: ~60 h
Step 10A(i–iii), downloading the reference set for minimac: ~15 min
Step 10A(iv–viii), creating the input files for imputation: ~5 min
Step 10A(ix), using MaCH for phasing per chunk: ~15 h
Step 10A(x), imputation with minimac: ~45 h
Step 10B, IMPUTE2: ~7 h
Step 10B(i,ii), downloading the reference set for IMPUTE2: ~10 min
Step 10B(iii–v), creating the input files for imputation: ~10 min
Step 10B(vi), using SHAPEIT for phasing per chromosome: varies per chromosome from 1.5 h to 5.5 h
Step 10B(vii,viii), imputation with IMPUTE2 per chunk: ~1 h
Inexperienced analysts will typically require more time. The estimated times and memory requirements are based on the  
target and reference sets used in this protocol; the estimates may also vary with different cohort designs. Moreover, given 
the computational nature of this protocol, timing will also heavily depend on the computational resources that are  
available to the analyst, and to a lesser extent on the versions of the tools. The phasing and imputation steps are the  
most time-consuming steps.
antIcIpateD results
converting the target set to the correct build
The genome-wide SNP data used in this protocol consists of 1,919 samples and 313,878 markers after performing  
quality control. After lifting this data set over from hg17 to hg19, the data set consists of 1,919 samples and  
304,930 markers.
Imputation with MacH and minimac
Imputation with minimac results in eight files per chunk. Each file is a compressed (zipped) file. If needed,  
such a file can be decompressed by running ‘gunzip -c filename.gz > filename’. Given the command for minimac  
specified earlier, the names of the output files start with ‘hunk1-clean-GWA-data.HG19.for-impute.merlin.chr1’ for  
chunk 1 of chromosome 1:
•  a file with the extension ‘.dose.gz’, which contains the imputed dosage for each genotype. Each row in the output will 
include one column per marker.
•  a file with the extension ‘.erate.gz’, which contains the error rate per marker.
•  a file with the extension ‘.hapDose.gz’, which contains the dosage for each haplotype separately.
•  a file with the extension ‘.haps.gz’, which contains the most likely alleles for each haplotype separately.
•  a file with the extension ‘.info.draft’, which contains the reference allele, nonreference allele and frequency per marker.  
It also lists the markers that were genotyped.
•  a file with the extension ‘.info.gz’, which contains the information about reference allele, frequencies and quality of  
imputations per marker. It also lists the markers that were genotyped.
•  a file with the extension ‘.prob.gz’, which contains the imputed probabilities for each genotype. Each row in the output 
will include two columns per marker. The first of these columns denotes the probability of a homozygote for allele 1.  
The second column denotes the probability of a heterozygote.
•  a file with the extension ‘.rec.gz’, which contains the switch error rate per interval.
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Imputation with IMpute2
Imputation with IMPUTE2 results in five files per chunk. Given the command for IMPUTE2 specified earlier, the names of the 
output files start with ‘clean-GWA-data.HG19.for-impute.plink.chr1.phased.chunk1.impute2’ for chunk 1 of chromosome 1:
•  a file without any extra extension: this file contains the main results of the imputations. The first five entries of each line 
should be the SNP ID, rs ID of the SNP, base-pair position of the SNP, the allele coded A and the allele coded B. The subsequent 
columns contain the probabilities for the three genotypes AA, AB and BB for the each individual in the target set. This format 
allows for genotype uncertainty, and therefore the probabilities for a given individual need not sum to 1.
•  a file with the extension ‘_info’: this file contains the following columns— SNP identifier, rsID, base-pair position,  
expected frequency of allele coded 1, measure of the observed statistical information associated with the allele  
frequency estimate, average certainty of best-guess genotypes and the internal ‘type’ assigned to SNP.
•  a file with the extension ‘_info_by_sample’, which contains the concordance and the R2 per sample.
•  a file with the extension ‘_summary’, which contains a summary of the screen output.
•  a file with the extension ‘_warnings’, which contains all warnings generated by IMPUTE2. 
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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Supplementary Figure 1 
The walltimes when splitting up the data set. 
The walltimes per job for MaCH (a, c, e) and minimac (b, d, f) for various ways of splitting up the data set. The walltime is the time as 
measured by a clock on the wall (CPU time, disk writing etcetera) required to impute the target set. The walltime per job for running
MaCH fits the linear regression models t=8.6 + 1.13n (Figure a), t=86.49 + 270.02n (Figure c) and t=1568.3 + 2.7n (Figure e). The 
walltime per job for running minimac fits the linear regression model t=33.8 + 0.13n (split before MaCH (blue circles)), t=50.2 + 0.10n
(split after MaCH (green squares)) (Figure b), t=688.6 + 3.29n (Figure d) and t=687.7 + 0.02n (Figure f). t is the walltime in minutes and 
n the number of samples (a, b), the size of the chunks in Mb (c, d) and the percentage of overlap (e, f). The percentage overlap is 10% 
in Figure c and d and the chunk size is 5Mb in Figure e and f.
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